Related scientific articles (all)

A non-randomized dose-escalation Phase I trial of a protein-based immunotherapeutic for the treatment of breast cancer patients with HER2-overexpressing tumors.

Authors : Limentani SA, Campone M, Dorval T, Curigliano G, de Boer R, Vogel C, White S, Bachelot T, Canon JL, Disis M, Awada A, Berlière M, Amant F, Levine E, Burny W, Callegaro A, de Sousa Alves PM, Louahed J, Brichard V, Lehmann FF
Year : 2016
Journal : Breast Cancer Res Treat
Volume : 156(2)
Pages : 319-30

RAS/MAPK activation is associated with reduced tumor-infiltrating lymphocytes in triple-negative breast cancer: therapeutic cooperation between MEK and PD-1/PD-L1 immune checkpoint inhibitors.

Authors : Loi S, Dushyanthen S, Beavis PA, Salgado R, Denkert C, Savas P, Combs S, Rimm DL, Giltnane JM, Estrada MV, Sanchez V, Sanders M, Cook RS, Pilkinton MA, Mallal SA, Wang K, Miller VA, Stephens PJ, Yelensky R, Doimi FD, Gomez H, Ryzhov SV, Darcy PK, Arteaga CL, Balko JM
Year : 2016
Journal : Clin Cancer Res
Volume : 22(6)
Pages : 1499-509

Cohort Selection and Management Application Leveraging Standards-based Semantic Interoperability and a Groovy DSL.

Authors : Bucur A, van Leeuwen J, Chen NZ, Claerhout B, de Schepper K, Perez-Rey D, Paraiso-Medina S, Alonso-Calvo R, Mehta K, Krykwinski C
Year : 2016
Journal : AMIA Jt Summits Transl Sci Proc
Volume : 2016
Pages : 25-32

Lapatinib-Related Rash and Breast Cancer Outcome in the ALTTO Phase III Randomized Trial.

Authors : Sonnenblick A, de Azambuja E, Agbor-Tarh D, Bradbury I, Campbell C, Huang Y, Dueck AC, Pritchard KI, Wolff AC, Jackisch C, Lang I, Untch M, Smith I, Boyle F, Xu B, Gomez H, Perez EA, Piccart-Gebhart M, Azim HA Jr
Year : 2016
Journal : J Natl Cancer Inst
Volume : 108

Noninvasive ventilation during acute respiratory distress syndrome in patients with cancer: Trends in use and outcome.

Authors : Neuschwander A, Lemiale V, Darmon M, Pène F, Kouatchet A, Perez P, Vincent F, Mayaux J, Benoit D, Bruneel F, Meert AP, Nyunga M, Rabbat A, Mokart D, Azoulay E
Year : 2016
Journal : J Crit Care
Volume : 38
Pages : 295-299

Analyse de : « Tinzaparine ou antivitamines K pour le traitement d’une thromboembolie veineuse dans le contexte d’un cancer ?

Authors : Sculier C
Year : 2016
Journal : Minerva.ebm
Volume : -
Pages : -

Mesenchymal stromal cells and immunomodulation: A gathering of regulatory immune cells.

Authors : Najar M, Raicevic G, Fayyad-Kazan H, Bron D, Toungouz M, Lagneaux L
Year : 2016
Journal : Cytotherapy
Volume : 18
Pages : 160-71

Metastatic breast cancer: The Odyssey of personalization.

Authors : Sonnenblick A, Pondé N, Piccart-Gebhart M
Year : 2016
Journal : Mol oncol
Volume : 10(8)
Pages : 1147-59

Outcome of uterine sarcoma patients treated with pazopanib: A retrospective analysis based on two European Organisation for Research and Treatment of Cancer (EORTC) Soft Tissue and Bone Sarcoma Group (STBSG) clinical trials 62043 and 62072.

Authors : Benson C, Ray-Coquard I, Sleijfer S, Litière S, Blay JY, Le Cesne A, Papai Z, Judson I, Schöffski P, Chawla S, Gil T, Piperno-Neumann S, Marréaud S, Dewji MR, van der Graaf WT
Year : 2016
Journal : Gynecol Oncol
Volume : 142(1)
Pages : 89-94

Targeted adjuvant therapy in breast cancer.

Authors : Zardavas D, Tryfonidis K, Goulioti T, Piccart-Gebhart M
Year : 2016
Journal : Expert Rev Anticancer Ther
Volume : 16(12)
Pages : 1263-75

Time trends in axilla management among early breast cancer patients: Persisting major variation in clinical practice across European centers.

Authors : Gondos A, Jansen L, Heil J, Schneeweiss A, Voogd AC, Frisell J, Fredriksson I, Johansson U, Tvedskov TF, Jensen MB, Balslev E, Hartmann-Johnsen OJ, Sant M, Baili P, Agresti R, van de Velde T, Broeks A, Nogaret JM, Bourgeois P, Moreau M, Mátrai Z, Sávolt Á, Nagy P, Kásler M, Schrotz-King P, Ulrich C, Brenner H
Year : 2016
Journal : Acta oncol (Stockholm)
Volume : 55(6)
Pages : 712-9

Endocrine treatment in breast cancer: Cure, resistance and beyond.

Authors : Tryfonidis K, Zardavas D, Katzenellenbogen BS, Piccart-Gebhart M
Year : 2016
Journal : Cancer Treat Rev
Volume : 50
Pages : 68-81

Side-effects of checkpoint inhibitor-based combination therapy.

Authors : Kourie HR, Klastersky J
Year : 2016
Journal : Curr Opin Oncol
Volume : 28
Pages : 306.13

16ème Rencontre Eveline Markiewicz sur les urgences et complications sévères chez le patient cancéreux. Revue Médicale de Bruxelles, 37 (2) :123-125 : 2016.37(2)

Authors : Sculier JP
Year : 2016
Journal : Rev Med Brux
Volume : 37(2
Pages : 123-5

A Phase II trial evaluating the efficacy of sorafenib (BAY 43-9006) and correlating early FDG PET-CT response to outcome in patients with recurrent and/or metastatic head and neck cancer.

Authors : Lalami Y, Garcia C, Flamen P, Ameye L, Paesmans M, Awada A
Year : 2016
Journal : Head Neck
Volume : 38(3)
Pages : 347-54

Difficulties and limitations in conducting translational research in thoracic oncology. A practical example.

Authors : Meert AP, Ameye L, Leclercq N, Paesmans M, Remmelink M, Sculier JP, Berghmans T
Year : 2016
Journal : Rev Mal Respir
Volume : 33(7)
Pages : 594-9

Health-related quality of life in locally advanced and metastatic breast cancer: methodological and clinical issues in randomised controlled trials.

Authors : Ghislain I, Zikos E, Coens C, Quinten C, Balta V, Tryfonidis K, Piccart-Gebhart M, Zardavas D, Nagele E, Bjelic-Radisic V, Cardoso F, Sprangers MA, Velikova G, Bottomley A
Year : 2016
Journal : Lancet Oncol
Volume : 17
Pages : e294-304

The Glasgow inflammatory score and lung cancer: A predictor of admissions to emergency units].

Authors : Gorham J, Ameye L, Paesmans M, Berghmans T, Sculier JP, Meert AP
Year : 2016
Journal : Rev Mal Respir
Volume : 33(9)
Pages : 759-65

Soft tissue sarcoma of the extremities: pending questions on surgery and radiotherapy.

Authors : Hoefkens F, Dehandschutter C, Somville J, Meijnders P, Van Gestel D
Year : 2016
Journal : Radiat Oncol
Volume : 11
Pages : 136

Reply to the letter to the editor 'Utilisation of the ESMO-MCBS in practice of HTA' by Wild et al.

Authors : Cherny NI, Sullivan R, Dafni U, Bogaerts J, Kerst JM, Zielinski C, Piccart-Gebhart M, de Vries EG
Year : 2016
Journal : Ann Oncol
Volume : 27(11)
Pages : 2136-7